Innovent and Chi-Med Add Second Chi-Med Drug to Combo Partnership

Life Science

China Grand Pharma Pays $30 Million for Majority Stake in US-Based OncoSec

Life Science

Chenguang Biotech to Build USD30 Million Tomato Processing Plant in California

Life Science

Chi-Med Starts Global Trial of Syk Inhibitor In Lymphoma Patients

Life Science

CTFH and Insilico Form $200 Million AI-Based Drug Discovery Partnership

Life Science

CBMG Announces Plans to Build US R&D Facility for Immunotherapies

Life Science

Beijing Gene+ Completes $28 Million B Round for Genetic Test Services

Life Science

Innovent Bio Completes $300 Million Secondary Offering in Hong Kong

Life Science

UK-Based Tech Investor Notion Capital Raises $150 Million for New Fund

Life Science

Merck’s Keytruda Approved as Monotherapy for Lung Cancer in China

Life Science

Simcere In-licenses Novel Gout Treatment from JW Pharma of Korea

Life Science

Hrain Biotech Raises $28 Million in B Round for Immunotherapies

Life Science

IASO and Innovent Approved to Start Trial of Novel CAR-T Immunotherapy

Life Science

Guanhao Bio Pays $3.1 Million to Acquire Stake in US-based ZY Therapeutics

Life Science

Sinopharm Invests in US Aesthetics Company; Acquires China Rights to Gel Implant

Life Science